Skip to main content
SpringerLink
Log in

Herzrhythmusstörungen

  • Chapter
Pharmakotherapie

Part of the book series: Springer-Lehrbuch ((SLB))

  • 2792 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Weiterführende Literatur

  • The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators (2003) A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med. 347: 1825–1833.

    Google Scholar 

  • Antoni H, Weirich J (1990) Neue Aspekte der elektrophysiologischen Wirkung von Antiarrhythmika. Herz 15: 61

    PubMed  CAS  Google Scholar 

  • Bigger JT et al. (1984) Multicenter post-infarction research group. The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infacrtion. Circulation 69: 250

    PubMed  Google Scholar 

  • Cairns JA et al. (1997) Randomized trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarizations: CAMIAT. Lancet 349: 675

    Article  PubMed  CAS  Google Scholar 

  • Dhein S et al. (1993) Comparative study on the proarrhythmic effects of some antiarrhythmic agents. A mapping study. Circulation 87: 617

    PubMed  CAS  Google Scholar 

  • Dhein S (2000) Arzneimittel-induzierte QT-Prolongation und Torsade de Pointes. Deutsche Med Wochenschrift 125: 703–708

    Article  CAS  Google Scholar 

  • Dhein S (2003) Antiarrhythmic drugs. In: Offermanns S, Rosenthal W: An Encylopedic Reference of Molecular Pharmacology. Springer Verlag, Heidelberg

    Google Scholar 

  • Echt DS and the CAST-Investigators (1991) Mortality and morbidity in patients receiving ecainide, flecainide or placebo. N Engl J Med. 324: 781

    Article  PubMed  CAS  Google Scholar 

  • Fetsch T, Bauer P, Engberding R et al. (2004) Prevention of atrial fibrillation after cardioversionet: results of the PAFAC trial. Eur Heart J. 25: 1385–1394

    Article  PubMed  Google Scholar 

  • Flaker GC et al. (1992) Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. The stroke prevention in atrial fibrillation invetsigators. J Am Coll Cardiol. 20: 527

    Article  PubMed  CAS  Google Scholar 

  • Gülker, H. et al. (1980) Kombinierte Behandlung chronischer Vorhofrhythmusstörungen mit Chinidin-Verapamil. Med. Klin. 75: 196

    PubMed  Google Scholar 

  • ISIS-4 Collaborative Group: ISIS-4 (1995) a randomizedfactorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58050 patients with suspected acute myocardial infarction. Lancet 345: 669

    Article  Google Scholar 

  • Julian DG et al. (1997) Randomized trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction. Lancet 349: 667

    Article  PubMed  CAS  Google Scholar 

  • Kowey PR, Yan GX, Winkel E, Kao W (2003) Pharmacologic and nonpharmacologic options to maintain sinus rhythm: guideline-based and new approaches. Am J Cardiol 91: 33D–38D

    Article  PubMed  CAS  Google Scholar 

  • Lenz TL, Hillemann DE (2000) Dofetilide: a new antiarrhythmic agent approved for conversion and/or maintenance of atrial fibrillation. Drugs Today 36: 759–771

    Article  PubMed  CAS  Google Scholar 

  • Lown, B., Wolf, M. (1971) Approaches to sudden death from coronary heart disease. Circulation 44: 130, 1971

    PubMed  CAS  Google Scholar 

  • Lüderitz, B.: Therapie der Herzrhythmusstörungen. Springer Verlag, Berlin

    Google Scholar 

  • Moss AJ et al. (1996) Improved survival with an implanted defibrllator in patients with coronary disease at high risk for ventricular arrhythmia. New Engl J Med. 335: 1933

    Article  PubMed  CAS  Google Scholar 

  • Nusser E, Trieb G (1990) Herzrhythmusstörungen. UTB Schattauer, Stuttgart

    Google Scholar 

  • Pfisterer ME et al. (1993) Long term benefit of 1-year amiodarone treatment for persistent complex ventricular arrhythmias after myocardial infarction. Circulation 87: 309

    PubMed  CAS  Google Scholar 

  • Prystowsky EN, Klein GJ (1994) Cardiac Arrhythmias. McGraw-Hill, New York

    Google Scholar 

  • Rosen MR, Janse MJ, Wit AL (Hrsg) (1990) Cardiac Electrophysiology: A Textbook. Futura: Mount Kisco, New York

    Google Scholar 

  • Roy D et al. (2000) Amiodarone to prevent recurrence of atrial fibrillation. New Engl J Med. 342: 913

    Article  PubMed  CAS  Google Scholar 

  • Scheininger J, Wehling M (1996) Adenosin als Antiarrhythmikum. Dtsch. Med. Wschr. 121: 139

    PubMed  CAS  Google Scholar 

  • Singh BN, Singh NS, Reda DJ, et a. (2005) Amiodaron versus Sotalol for atrial fibrillation. N Engl J Med. 352: 1861–1872

    Article  PubMed  CAS  Google Scholar 

  • The European Atrial Fibrillation Trial Study Group (1995) Optimal oral anticoagulant therapy in patients with non-rheumatic atrial fibrillation and recent cerebral ischemia. New Engl J Med. 333: 5

    Article  Google Scholar 

  • Van Gelder IC, Hagen VE, Bosker HA et al. (2002) A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med. 347: 1834–1840

    Article  PubMed  Google Scholar 

  • Waldo AL et al. (1996) Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infacrtion. The SWORD Investigators. Survival With Oral d-Sotalol. Lancet 348: 7

    Article  PubMed  CAS  Google Scholar 

  • Woods KL (1992) Intravenous magnesium suphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2). Lancet 339: 1553

    Article  PubMed  CAS  Google Scholar 

  • Zipes DP, Jalife J (1995) Cardiac Electrophysiology. From Cell to Bedside. Saunders, Philadelphia

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Herzzentrum Klinik für Herzchirurgie, Universität Leipzig, Strümpellstr. 39, 04289, Leipzig

    Prof. Dr. med. Stefan Dhein

  2. Herzzentrum Leipzig, Russenstr. 19, 04289, Leipzig

    OA PD Dr. med. Gerhard Hindricks

Authors
  1. Prof. Dr. med. Stefan Dhein
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. OA PD Dr. med. Gerhard Hindricks
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Institut für Pharmakologie und Toxikologie, Fakultät für Klinische Medizin Mannheim, Ruprecht-Karls-Universität Heidelberg, Maybachstraße 14, 68169, Mannheim

    Björn Lemmer

  2. Institut für Experimentelle und Klinische Pharmakologie und Toxikologie, Friedrich-Alexander-Universität Erlangen-Nürnberg, Fahrstraße 22, 91054, Erlangen

    Kay Brune

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Dhein, S., Hindricks, G. (2007). Herzrhythmusstörungen. In: Lemmer, B., Brune, K. (eds) Pharmakotherapie. Springer-Lehrbuch. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-34181-9_18

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-34181-9_18

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-34180-2

  • Online ISBN: 978-3-540-34181-9

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation